The San Diego based company is focused on addressing unmet needs in global health and biodefense with the Aethlon Hemopurifier, a therapeutic device designed for the rapid depletion of circulating viruses and cancer promoting exosomes.
Aethlon Medical CEO says 'time is right' to move Aethlon Hemopurifier to human studies
Quick facts: Aethlon Medical Inc
Price: 1.82 USD
Market Cap: $22 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE